Oral vitamin D rapidly attenuates inflammation from sunburn: an interventional study.
J Invest Dermatol. 2017 May 30. pii: S0022-202X(17)31558-0. doi: 10.1016/j.jid.2017.04.040. [Epub ahead of print]
Scott JF1, Das LM2, Ahsanuddin S2, Qiu Y3, Binko AM2, Traylor ZP2, Debanne SM3, Cooper KD4, Boxer R5, Lu KQ6.
This small RCT gave 200,000 IU of vitamin D 1 hour after intense (3MED) UV on one arm
For years we have suspected that Vitamin D both prevents and treats sunburns
This RCT confirms that ORAL Vitamin D can TREAT sunburn
The founder of VitaminDWiki believes that TOPICAL vitamin D is as good or perhaps better
Strangely, the publisher charged $46 for the PDF in April but gave it away for free in June
See also VitaminDWiki
The diverse immunomodulatory effects of vitamin D are increasingly being recognized. However, the ability of oral vitamin D to modulate acute inflammation in vivo has not been established in humans. In a double-blinded, placebo-controlled interventional trial, twenty healthy adults were randomized to receive either placebo or a high dose of vitamin D3 (cholecalciferol) one hour after experimental sunburn induced by an erythemogenic dose of ultraviolet radiation.
Compared to placebo, participants receiving vitamin D3 (200,000 IU) demonstrated reduced expression of pro-inflammatory mediators TNF-α (p=0.04) and iNOS (p=0.02) in skin biopsy specimens 48 hours after experimental sunburn. A blinded, unsupervised hierarchical clustering of participants based on global gene expression profiles revealed that participants with significantly higher serum vitamin D3 levels after treatment (p=0.007) demonstrated increased skin expression of the anti-inflammatory mediator arginase-1 (p=0.005), and a sustained reduction in skin redness (p=0.02), correlating with significant expression of genes related to skin barrier repair.
In contrast, participants with lower serum vitamin D3 levels had significant expression of pro-inflammatory genes. Together the data may have broad implications for the immunotherapeutic properties of vitamin D in skin homeostasis, and implicate arginase-1 up regulation as a previously unreported mechanism by which vitamin D exerts anti-inflammatory effects in humans.
PMID: 28576736 DOI: 10.1016/j.jid.2017.04.040
Download the manuscript PDF from VitaminDWiki
Editorial covering the study
A vitamin to D-crease sunburn
Tiffany C. Scharschmidt
Science Translational Medicine 14 Jun 2017: Vol. 9, Issue 394, eaan5233 DOI: 10.1126/scitranslmed.aan5233
High doses of oral vitamin D3 attenuate skin inflammation following experimentally induced sun damage.
Summer is upon us; so what to do if you forget to reapply your sunscreen? To avoid a nasty sunburn, Scott et al. suggest we could reach for vitamin D rather than aloe vera. Produced in the skin following ultraviolet (UV) light exposure and then hydoxylated to its active form in the liver and kidney, vitamin D has long been recognized as critical for calcium homeostasis and bone health. Although recently touted to reduce cancer risk, cardiovascular disease, and susceptibility to infections and autoimmunity, there is as yet insufficient evidence to recommend dietary supplementation for any of these extra-skeletal indications.
Scott et al. report a randomized, double-blinded pilot study designed to test whether vitamin D attenuates skin inflammation following UV-induced injury— i.e., sunburn. Twenty healthy adult subjects received either placebo or one of three oral vitamin D3 doses 1 hour after controlled exposure to UV light. Compared with placebo and lower doses tested, 200,000 IU of vitamin D3 reduced visible redness and histologic evidence of structural skin damage assessed at 48 hours. These protective effects were associated with dose-dependent reductions in skin expression of tumor necrosis factor–α and inducible nitric oxide synthase (iNOS), two key mediators of UV-induced inflammation. Unsupervised hierarchical clustering based on results of whole-skin microarray revealed a subset of subjects with a gene signature characterized by reduced expression of proinflammatory mediators and skin barrier repair pathways. These “vitamin D responders,” most of whom had received high-dose vitamin D3, also had less skin redness and higher serum levels of 25-hydroxylated vitamin D post-intervention.
These intriguing results suggest that a single high-dose of oral vitamin D mitigates inflammatory sequelae of UV-induced skin injury. Although the authors note that arginase-1, which has the capacity to reduce iNOS, was up-regulated in skin macrophages of “vitamin D responders,” the mechanisms for vitamin D-associated protection from skin inflammation remain unknown. Assuming these findings are replicated in a larger study, we also need to understand whether high-dose vitamin D could increase mutation rates by uncoupling UV injury from immune-mediated tissue repair and removal of damaged keratinocytes. For now, this dermatologist will keep her sunscreen close by.